Valiant Laboratories Limited (NSE:VALIANTLAB)
India · Delayed Price · Currency is INR 66.76
-0.46 (-0.68%)
Feb 10, 2026, 3:29 PM IST
Valiant Laboratories Market Cap
Valiant Laboratories has a market cap or net worth of 3.63 billion as of February 10, 2026. Its market cap has decreased by -23.87% in one year.
Market Cap
3.63B
Enterprise Value
3.54B
Revenue
1.86B
Ranking
n/a
PE Ratio
64.77
Stock Price
66.76
Market Cap Chart
Since October 6, 2023, Valiant Laboratories's market cap has decreased from 7.40B to 3.63B, a decrease of -50.95%. That is a compound annual growth rate of -26.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 3.65B | -3.97% |
| Dec 31, 2025 | 3.80B | -21.26% |
| Dec 31, 2024 | 4.83B | -35.84% |
| Dec 29, 2023 | 7.53B | 1.73% |
| Oct 6, 2023 | 7.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beta Drugs | 13.93B |
| Jagsonpal Pharmaceuticals | 11.25B |
| Ind-Swift Laboratories | 10.79B |
| Sakar Healthcare | 9.73B |
| Sigachi Industries | 9.17B |
| Bafna Pharmaceuticals | 2.74B |
| Nectar Lifesciences | 2.61B |
| Brooks Laboratories | 1.79B |